Operator
Operator
Greetings and welcome to the Proto Labs Third Quarter 2015 Earnings Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Bill Dietrick. Please go ahead, sir. William M. Dietrick - VP-Global Marketing & Head-Media Relations: Thank you, operator, and good morning, everyone. This morning, before the market opened, Proto Labs issued a press release announcing its third quarter financial results for the quarter ended September 30, 2015. The release is available on the company's website at protolabs.com. Before we get started, during the course of this conference call, the company will provide financial projections and make other statements about its business that are forward-looking and subject to many risks and uncertainties that could cause actual results to differ materially from expectations. A detailed discussion of the risks and uncertainties that affect the business is contained in the company's Annual Report filed on Form 10-K and other SEC filings, particularly under the heading Risk Factors. Copies of these filings are available online from the SEC or on the Proto Labs' website. The company's projections and other forward-looking statements are based on factors that are subject to change, and, therefore, these statements speak only as of the date they are given. The company does not undertake to update any projection or forward-looking statement. In addition, to supplement the GAAP numbers, we have provided revenue growth on a constant currency basis, non-GAAP operating margins, and non-GAAP adjusted net income and basic and diluted net income per share information. The non-GAAP operating margin information excludes costs of stock compensation, amortization of intangibles, and transaction costs related to the Alphaform acquisition. The non-GAAP adjusted net income excludes the after-tax costs of stock compensation, amortization of intangibles, the non-cash unrealized foreign currency activity, and transaction costs related to the Alphaform acquisition. We believe that these non-GAAP metrics provide meaningful supplemental information, are indicative of our core operating results, and are helpful in assessing our historical and future performance. A table reconciling the GAAP information to the non-GAAP information is included in our financial release. Now, I'd like to turn the call over to Vicki Holt, President and Chief Executive Officer, Proto Labs. Vicki? Victoria M. Holt - President & Chief Executive Officer: Thank you, Bill. Good morning, everyone. Thank you for joining us on our third quarter conference call. With me today is John Way, our Chief Financial Officer. I will begin with an overview of the third quarter financial performance and some operational highlights. Then I'll offer some insights into our recently completed acquisition of the operations of Alphaform. Finally, I'll provide an update on some of our strategic initiatives during the quarter. John will conclude our formal remarks with a more detailed look at our third quarter financial results and our outlook for the fourth quarter of 2015. Following that, we will be happy to take your questions. Proto Labs generated $67.8 million in revenue in the third quarter, at the top end of our guidance. This represents an increase of 24% over the third quarter of 2014 and set another quarterly record for the company. On a constant currency basis, adjusted for the $2.1 million negative revenue impact of foreign currency in the quarter, revenue grew 28%. We also achieved record net income in the quarter of $12.4 million or $0.47 per diluted share. Excluding the after-tax costs of stock compensations, amortization of intangibles, transaction costs related to the Alphaform acquisition and the non-cash unrealized gain related to foreign currency translation, non-GAAP net income was $13.7 million or $0.52 per diluted share. Our success this quarter is once again attributable to the focused and strong execution of our strategy by our employees. Revenue from our Fineline additive manufacturing business grew 79% compared with the third quarter last year to $6 million. The strength in additive manufacturing continues to reflect growing customer awareness of our additive manufacturing capability as well as the strength of our cross-selling efforts. Additive manufacturing revenue represented 9% of our total revenue in the third quarter. We anticipate additive manufacturing to remain a significant growth engine for the company. To ensure we can accommodate the current and future demand we expect, we are focused on completing the necessary infrastructure improvements and installing machinery and other equipment at our newly purchased 77,000 square foot facility in Raleigh, North Carolina. You'll recall that we will be consolidating two smaller facilities with a total of 21,000 square feet into this new building and further expanding our capacity there. It is scheduled for completion by early 2016, and we are on track to meet this timeframe. Our additive manufacturing efforts in the UK continued to gain momentum. Our full launch began at the end of third quarter, and orders for our stereolithography services in Europe are building. And importantly, the acquisition of Alphaform will accelerate the growth of our additive manufacturing business in Europe. I will provide more details on the acquisition shortly, but first, I'd like to turn our attention to our other two service lines. Firstcut CNC Machining service revenue increased 28% compared with the prior year and set another quarterly record. In constant currency, Firstcut revenue grew 31%. Our CNC Machining business has benefited from the lathe offering introduced in North America in Q1 and Europe in the second quarter. Protomold third quarter revenue set another record and grew 18% year-over-year. The growth was 22% on a constant currency basis. Third quarter Protomold revenue grew $2 million sequentially, and we expect continued healthy growth in this business. We recognize that Protomold growth is slightly lower than our 25% overall target. The market for prototype and low-volume custom injection molded parts is large, and we are seeing no particular increase in competition. We've completed a successful first year with additive manufacturing fully integrated as a third service offering, and the results have been excellent. This was accomplished with focused sales and marketing efforts to drive this growth. We're still completing our 2016 sales and marketing plans and expect to shift the mix of our marketing activities and provide more tailored sales incentives to ensure each of our services are meeting their growth goals. We're confident that with focused marketing efforts and some changes in our sales incentives, we will see enhanced growth rates in Protomold. Looking at revenue by region, sales in North America increased 26% year-over-year led by strong additive manufacturing and CNC Machining growth. Revenue growth in Europe grew 40% on a constant currency basis as compared to 21% when converted to U.S. dollars, reflecting the continued strong execution in the region. We also continued our strong performance in Japan with revenue up 14% or 33% growth on a constant currency basis. During the quarter, we launched our lathe service in Japan and began taking new orders for this service. I'd like to turn now to some discussion on our recent acquisition of Alphaform. Alphaform AG was a leading service bureau headquartered in Germany. It serves product developers and engineers through additive manufacturing and injection molding. The company specializes in the same additive manufacturing technologies we offer: stereolithography, selective laser sintering, and direct metal laser sintering. We purchased the assets and operations associated with these capabilities in facilities located in Germany, Finland, and the UK. This acquisition is very complementary to our business and will significantly accelerate our additive manufacturing growth in Europe. We will leverage Alphaform's manufacturing assets, customer base, and experienced workforce to accelerate our growth by quickly and cost effectively integrating this business into our existing European operations. And the addition of Alphaform's stereolithography capability will augment our recently launched operation in the UK. In addition, Alphaform allows us to provide SLS and DMLS services immediately. We are very pleased to have a major presence and manufacturing operation in Germany, the largest single market for our services in Europe. Alphaform has a particular strength in the automotive industry, and also serves customers across a wide variety of additional end use verticals. Alphaform has strong brand recognition and is known for the quality of the parts it manufactures. The business was forced into bankruptcy due to poor financial decisions and bad contracts. Alphaform had also entered into several sale/lease-back transactions at unfavorable terms. We are in the process of winding down the unfavorable contracts and implementing our business discipline to turn this operation around. The transaction will be slightly dilutive to our earnings per share for the next few quarters as we integrate the operations into our business. The acquisition was structured as an asset purchase and included the purchase of select assets and operations of Alphaform, excluding MediMet, a medical casting business that does not currently fit our operating model. The total purchase price, including the buyout of some equipment leases, was approximately $10 million. We anticipate that run-rate revenue will be approximately $4 million a quarter after we have exited the unfavorable contracts. The integration process has begun, and we will be working through this over the next several quarters. We have been in contact with Alphaform customers and so far, the reception has been quite positive. We are thrilled to welcome the Alphaform team members to Proto Labs, and they are excited to begin implementing Proto Labs' strong technology-based e-commerce business model utilizing their manufacturing assets. We will continue to take orders and build parts using our stereolithography capabilities in Telford, England as well as Germany. The legacy Alphaform operations will be managed under the leadership of John Tumelty, our VP/GM for the European region. We are very excited about this opportunity, which we believe will help drive Proto Labs to the next level in Europe. John Way will provide a few more financial details in his comments. Finally, I'd like to provide an update on some of our strategic initiatives. We continue to invest in our business to sustain our high growth rates, while delivering on our brand promise to our customers. This included investments in human resources, training, IT infrastructure, manufacturing quality and continuous improvement and manufacturing assets. We added another 43 pieces of manufacturing equipment across all three of our services in the quarter, bringing our total to 630. We also continue to invest in our customer-facing organization with the addition of 14 more professionals to bring our total to over 250 team members globally. A key goal for 2015 is to expand our envelope of services globally. I've mentioned the full launch of stereolithography in the UK and its positive reception to-date. The lathe process has been another important service offering. We launched lathe-turned parts in North America in the first quarter, Europe the second quarter and as planned, we launched lathe services in Japan last month. Customer interest in lathe-turned parts continues to expand and we anticipate growing demand in 2016. We've been very pleased in the continued sales growth of liquid silicone rubber molds and LSR parts, part of our Protomold offering. Our magnesium injection molding, sometimes called thixomolding and metal injection molding are more of a specialty niche offering that are providing our customers with alternative to CNC Machining for higher volumes of metal parts. From inception, Protomold has been committed to encouraging and supporting innovation in industrial design. Since 2011, our Cool Idea! Award program has provided more than $1 million in prototyping and short-run production services to entrepreneurs working on new products in the U.S. and Europe. We granted two Cool Idea! Awards in the third quarter. In July, we gave an award to the creators and developers of Wristify, a wearable bracelet that cools or heats the skin. This brings comfort to the wearer in rooms that they may perceive to be too hot or too cold. The ultimate goal of Wristify is to help reduce energy consumption by focusing on adjusting the temperature based on the needs of the individual, not an entire building. In August, we granted a Cool Idea! Award to the developers of Compliant Games. This company has developed a respiratory system that uses video games to help pediatric and nursing home patients comply with respiratory therapy requirements. We are very proud to support these worthy new efforts. And finally, we were honored to be named by one of Fortune Magazine's top 100 Fastest-Growing Companies in our first year of eligibility. This is the magazine's annual compilation of public companies with the best annualized revenue, profit and stock growth over a three-year period. Proto Labs ranked 75th on the list with 28% growth in revenue, 36% growth in EPS and an annualized stock return of 33% over the past three years. This is a record to be proud of, driven by the commitment to excellent execution day-in and day-out by our employees. And the third-quarter results were a further demonstration of these efforts. With that, I will turn the call over to John Way for further comments on our financial performance. John? John A. Way - Chief Financial Officer & Head-Investor Relation: Thank you, Vicki. Revenue during the third quarter was $67.8 million, an increase of $13.3 million, or 24%, over the same quarter in 2014. Excluding the $2.1 million negative impact of currency in the quarter, revenue growth in constant currencies was 28% year-over-year. Protomold, Firstcut and Fineline revenues were $42 million, $19.8 million and $6 million respectively. Revenue in the third quarter came from 12,541 unique product developers and engineers, a 24% increase over the third quarter of 2014 and an increase of 719, or 6.1% sequentially. Average revenue per product developer increased 3% on a constant currency basis compared to the third quarter of last year. Gross profit for the quarter was $40.3 million, an increase of $7.2 million over the comparable period for the prior year. Gross margin was 59.4%, an increase of 70 basis points from the second quarter gross margin of 58.7%, and a 120-basis-point decline from 60.6% in the third quarter last year. Foreign currency exchange rates had a negative impact on gross margins of 50 basis points year-over-year. The remaining year-over-year fluctuation primarily reflects the cost of ramping recently-launched services and capacity investments to ensure we meet our promise to customers to deliver quality custom parts with consistent reliability. Our additive manufacturing margin continues to improve as we gain efficiencies from the scaling of the business. This gross margin improvement has reduced the dilutive impact on gross margins from 90 basis points in Q2 to 50 basis points in Q3. Our operating expenses increased to $22.3 million, or 33.8% of revenue in the quarter compared with 32.3% in the prior year. These expenses for the quarter included transaction costs of $648,000 associated with the Alphaform acquisition. These costs have been added back to adjusted net income in our non-GAAP reporting. We continue to invest in our sales and marketing organization to drive the growth of our business. Sales and marketing expense of $10 million or 14.8% of revenue was consistent with our guidance. We also invested $4.8 million or 7% of revenue in research and development in the quarter, which was also in line with our previous guidance. During the quarter, we invested in certain activities to ensure we have the foundation necessary to support our future growth. These projects include IT systems updates and an upgrade to our ERP system, investments in employee recruiting, training, and development, and initial costs such as real estate taxes associated with our new facility in Raleigh, North Carolina. These investments will be ongoing and are now embedded in our run-rate. The quarter also included a number of non-recurring expenses. These items, while individually insignificant, aggregated to approximately $300,000. Examples include costs associated with launching additive manufacturing services in Europe, consulting costs associated with tax and compensation planning, and repairs and maintenance on our facilities. Reported net operating income was $17.4 million in the third quarter of 2015 compared to $15.4 million in the same quarter of 2014. On an adjusted non-GAAP basis, operating income increased to $19.8 million or 29.3% of revenue compared to $16.9 million or 31% of revenue in the prior year. Diluted earnings per share in the third quarter of 2015 were $0.47. Adding back the after-tax costs of stock compensation, amortization of intangibles, transaction costs, and the effect of the unrealized gain on foreign currency, our non-GAAP diluted earnings per share in the quarter were $0.52. Our capital spending during the third quarter of 2015 was $11.5 million and included payments on the building in North Carolina, manufacturing equipment across all our services, and computer software and hardware. As Vicki mentioned, we paid approximately $10 million for the Alphaform assets and operations. This includes $5.5 million for the transaction and approximately $5 million to buy out certain equipment leases. The lease buyouts were completed after the transaction and as a result are accounted for as capital expenses on the statement of cash flows. With the addition of the capital associated with the Alphaform transaction and equipment necessary for our continued growth, we expect capital expenditures of approximately $48 million in 2015. During the quarter, we continued to generate consistent operating cash flow of $13.5 million. Cash and investments increased $8 million from the prior quarter to $150 million at the end of September. I would now like to provide some guidance into our projected results for the fourth quarter. We currently expect Q4 2015 revenue to be in the range of $70 million to $74 million. This revenue guidance includes an estimated $4 million related to the acquisition of Alphaform, and an estimated $1.1 million negative impact related to the exchange rates compared to the fourth quarter of 2014. Adjusting for the estimated impact of Alphaform and the exchange rates, this guidance represents organic revenue growth in constant currencies of 20% to 27%. For the full year, we are projecting revenue of $260 million to $264 million. This represents revenue growth of 28% to 30% on a constant currency basis. We estimate that Alphaform will have a dilutive effect on gross margins of approximately 250 basis points in the fourth quarter. Additionally, we estimate the operations of Alphaform will be approximately $0.03 dilutive to fourth quarter earnings per share, and the integration-related costs will have an additional $0.01 to $0.02 dilution. We are working diligently to integrate the Alphaform operations into our existing systems, processes and operating model as quickly as possible. We anticipate Alphaform will remain dilutive to the company's financial results for the next few quarters, and project the Alphaform operation to become profitable in the second half of 2016. Stock compensation costs for the quarter will be approximately $1.6 million. Amortization of intangibles related to the Fineline acquisition will be approximately $185,000. We estimate an additional $200,000 of transaction costs in the fourth quarter. Taking into consideration all of the above, including the $0.04 to $0.05 dilution related to the Alphaform, we expect our quarterly non-GAAP EPS to be between $0.45 and $0.49 per share. This concludes our prepared remarks. Operator, we will now open up the line for questions.